Research and Markets (http://www.researchandmarkets.com/research/kdhj3v/post_menopausal) has announced the addition of the "Post Menopausal Osteoporosis - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Post Menopausal Osteoporosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Post Menopausal Osteoporosis and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Post Menopausal Osteoporosis Overview
  3. Therapeutics Development
  4. Pipeline Products for Post Menopausal Osteoporosis - Overview
  5. Pipeline Products for Post Menopausal Osteoporosis - Comparative Analysis
  6. Post Menopausal Osteoporosis - Therapeutics under Development by Companies
  7. Post Menopausal Osteoporosis - Therapeutics under Investigation by Universities/Institutes
  8. Post Menopausal Osteoporosis - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Post Menopausal Osteoporosis - Products under Development by Companies
  13. Post Menopausal Osteoporosis - Products under Investigation by Universities/Institutes
  14. Post Menopausal Osteoporosis - Companies Involved in Therapeutics Development
  • Amgen Inc.
  • Chronos Therapeutics Limited
  • Eli Lilly and Company
  • Hanmi Pharmaceuticals, Co. Ltd.
  • Ligand Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • Oncobiologics, Inc.
  • Paras Biopharmaceuticals Finland Oy
  • Pfizer Inc.
  • Radius Health, Inc.
  • Richter-Helm BioTec GmbH & Co. KG
  • Unigene Laboratories, Inc. (Inactive)

For more information visit http://www.researchandmarkets.com/research/kdhj3v/post_menopausal